These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 363486)

  • 1. Preventive treatment of migraine headache with a new isoergolenyl derivative.
    Herrmann WM; Kristof M; Sastre M; Sastre M
    J Int Med Res; 1978; 6(6):476-82. PubMed ID: 363486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Lisuride for the prevention of migraine. Results of a multicenter study].
    Soyka D; Frieling B
    Fortschr Med; 1989 Dec; 107(35):763-6. PubMed ID: 2691377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Migraine prophylaxis with Lisuride hydrogen maleate--a double blind study of Lisuride versus placebo.
    Somerville BW; Herrmann WM
    Headache; 1978 May; 18(2):75-9. PubMed ID: 348647
    [No Abstract]   [Full Text] [Related]  

  • 4. [Acid lysuride maleate in the prevention of migraine headache. Clinical experience].
    Franchi G; Mallucci C
    Minerva Med; 1983 Jul; 74(28-29):1749-53. PubMed ID: 6866307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lisuride as a migraine prophylactic in children: an open clinical trial.
    Del Bene E; Poggioni M; Michelacci S
    Int J Clin Pharmacol Res; 1983; 3(2):137-41. PubMed ID: 6679514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lisuride treatment of focal dystonias.
    Nutt JG; Hammerstad JP; Carter JH; deGarmo PL
    Neurology; 1985 Aug; 35(8):1242-3. PubMed ID: 3895034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lisuride in parkinsonism.
    Gopinathan G; Teräväinen H; Dambrosia JM; Ward CD; Sanes JN; Stuart WK; Evarts EV; Calne DB
    Neurology; 1981 Apr; 31(4):371-6. PubMed ID: 7194429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lisuride in Parkinson disease: efficacy of lisuride compared to levodopa.
    Lieberman A; Goldstein M; Neophytides A; Kupersmith M; Leibowitz M; Zasorin N; Walker R; Kleinberg D
    Neurology; 1981 Aug; 31(8):961-5. PubMed ID: 7022259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic effect of lisuride in advanced Parkinson's disease.
    Meneghetti G; Bracco F; Giometto B; Ferla S; Schergna E
    Eur Neurol; 1986; 25(1):74-80. PubMed ID: 3510126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute treatment of Huntington's chorea with lisuride.
    Frattola L; Albizzati MG; Alemani A; Bassi S; Ferrarese C; Trabucchi M
    J Neurol Sci; 1983 May; 59(2):247-53. PubMed ID: 6222164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lisuride versus bromocriptine treatment in Parkinson disease: a double-blind study.
    LeWitt PA; Gopinathan G; Ward CD; Sanes JN; Dambrosia JM; Durso R; Calne DB
    Neurology; 1982 Jan; 32(1):69-72. PubMed ID: 7033825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lisuride in dystonia.
    Quinn NP; Lang AE; Sheehy MP; Marsden CD
    Neurology; 1985 May; 35(5):766-9. PubMed ID: 3887215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lisuride treatment in Parkinson's disease: clinical and pharmacokinetic studies.
    LeWitt PA; Burns RS; Calne DB
    Adv Neurol; 1983; 37():131-40. PubMed ID: 6344586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Further studies with lisuride in Parkinson's disease.
    Lieberman AN; Goldstein M; Gopinathan G; Leibowitz M; Neophytides A; Walker R; Hiesiger E
    Eur Neurol; 1983; 22(2):119-23. PubMed ID: 6341071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of dopamine agonists in dystonia.
    Teräväinen H; Calne S; Burton K; Beckman J; Calne DB
    Adv Neurol; 1988; 50():571-8. PubMed ID: 3041762
    [No Abstract]   [Full Text] [Related]  

  • 16. Lisuride hydrogen maleate: evidence for a long lasting dopaminergic activity in humans.
    Liuzzi A; Chiodini PG; Oppizzi G; Botalla L; Verde G; De Stefano L; Colussi G; Gräf KJ; Horowski R
    J Clin Endocrinol Metab; 1978 Feb; 46(2):196-202. PubMed ID: 108287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation of the clinical effect of lisuride hydrogen maleate (SH-1072) on benign prostatic hypertrophy: on the clinical results and mechanism of action].
    Okada K; Yamauchi T; Oishi K; Hashimura T; Kawamura J; Yoshida O
    Hinyokika Kiyo; 1985 May; 31(5):885-93. PubMed ID: 2413748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of migraine attacks in children with dihydroergotamine Spofa and lysenyl].
    Vajnorský J
    Cesk Pediatr; 1986 Nov; 41(11):644-7. PubMed ID: 3814243
    [No Abstract]   [Full Text] [Related]  

  • 19. Suppression of puerperal lactation by terguride. A double-blind study.
    Venturini PL; Horowski R; Fasce V; Valenzano M; Ferreri C; Badino G; Rainer E; Scholz A; De Cecco L
    Gynecol Obstet Invest; 1988; 26(1):33-8. PubMed ID: 3049266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of efficacy of lisuride hydrogen maleate with increased doses of levodopa in parkinsonian patients.
    Rabey JM; Treves T; Streifler M; Korczyn AD
    Adv Neurol; 1987; 45():569-72. PubMed ID: 3825734
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.